Predilife S.A.

PAR • Healthcare • Diagnostics & Research • Quote as of 10/29/2026

Company Profile

IndustryDiagnostics & Research

SectorHealthcare

ExchangePAR

Market Capitalization3.35 mln

Float1.22 mln

Business Description

Predilife S.A. is a French company founded in 2004 that develops tools to help predict the likelihood of serious diseases before they occur. Its main offerings include MammoRisk, a personalized breast cancer risk test, and DenSeeMammo, a software tool that measures breast density. The company operates from its headquarters in Villejuif, France.

Key Fundamentals

EPS-1.00

ROE32.15

RPS0.21

ROIC332

ROA-95.48

Interest Cover-2.69

EBITDA, mln-2.80

EV / EBITDA-2.50

Revenue, mln0.84

EV / Revenue9.73

Quote Details

Last 0.85

Change -0.07 (-7.61%)

Open 0.84

Volume 2,412

Turnover 2,050.2

Average Volume 827.14

Financial Ratios

Pre-Tax Profit Margin-341

Current Ratio0.56

Price / Sales3.00

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-4.49%	9 / 100
1 Month	-16.67%	7 / 100
2 Months	-67.31%	1 / 100
6 Months	-72.58%	1 / 100
1 Year	-73.44%	2 / 100